Thank you for Subscribing to Med Tech Business Review Weekly Brief
MedTech Business Review proudly presents the Top 10 Chief Commercial Officers - 2026, recognizing leaders who are advancing commercial performance through strategic planning and market-focused leadership. These professionals oversee commercial strategies that align customer engagement, market opportunities, and growth initiatives with business objectives while responding to evolving healthcare needs. Their leadership helps organizations strengthen market positioning and expand commercial opportunities, enabling medtech companies to drive sustainable growth while supporting long-term business performance.
Top 10 Chief Commercial Officers - 2026
Chief Commercial Officer, Merit Medical Systems
C. Adam Smith serves as Chief Commercial Officer at Merit Medical Systems, heading the company's global commercial organization. Since joining Merit in 2018, he has held leadership roles, including international markets, marketing, franchises and regional operations, before becoming the CCO in 2025. His career reflects a focus on connecting commercial strategy with local market execution.
EVP, Chief Commercial Officer, Vertex Pharmaceuticals
Duncan McKechnie is Executive Vice President and Chief Commercial Officer at Vertex Pharmaceuticals. After joining the company in 2013, he progressed through commercial leadership roles spanning global strategy, North America operations, market access and pricing before assuming responsibility for the company's worldwide commercial organization. His career reflects a consistent focus on expanding patient access while preparing commercial teams for new therapeutic areas.
